VM
CLCD

VHCP Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

VHCP Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.48M Hold
68,190
– – 2.67% 9
2016
Q3 		$2.6M Buy
+68,190
New +$1.01M 2.56% 8

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

VHCP Management's CLCD Position: Q4 2016 in Review

VHCP Management held its CoLucid Pharmaceuticals, Inc. (CLCD) position steady in Q4 2016 at 68,190 shares worth $2.48M. The position accounts for 2.67% of the portfolio, ranked #9.

VHCP Management first reported a position in CLCD in Q3 2016 and has held it in 2 quarters since. The position peaked at $2.6M in Q3 2016. 76 funds tracked by Wall St. Rank hold CLCD as of Q4 2016.

  • VHCP Management held 68,190 shares of CoLucid Pharmaceuticals, Inc. worth $2.48M as of Q4 2016.
  • VHCP Management left its CoLucid Pharmaceuticals, Inc. share count unchanged in Q4 2016.
  • CoLucid Pharmaceuticals, Inc. made up 2.67% of VHCP Management's portfolio in Q4 2016, its #9 holding.
  • VHCP Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and has held it in 2 quarters since.
  • VHCP Management's CoLucid Pharmaceuticals, Inc. position peaked at $2.6M in Q3 2016.
  • 76 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.